This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Congestive Heart Failure/ Cardiomyopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

Out With the Old, In With the New

Philip A. Poole-Wilson, MD,FRCP

JAMA. 2002;287:1578-1580.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The phrase heart failure encompasses a variety of clinical syndromes. A simple and practical classification is acute heart failure (pulmonary edema), circulatory failure (cardiogenic shock), and chronic heart failure. Adjectives such as systolic and diastolic, overt, congestive, decompensated, undulating, treated, or compensated are commonly added to the latter syndrome. Other distinctions paraded as forward and backward, right- and left-sided, high- and low-output heart failure are rightly out of favor and limited to historical interest reflecting concepts that in large part have been shown to be incorrect. In the last few decades, there have been remarkable improvements in the treatment of chronic heart failure. The epidemiology and implications of heart failure for health care have been appreciated, understanding of the biology and physiology of heart failure has been advanced, new drugs have become available, and the progress in cardiac transplantation has been a catalyst for enthusiasm in . . . [Full Text of this Article]

Author Affiliation: Department of Cardiac Medicine, National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, England.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Intravenous Nesiritide vs Nitroglycerin for Treatment of Decompensated Congestive Heart Failure: A Randomized Controlled Trial

JAMA. ;287():1531-1540.
FULL TEXT  

Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart Failure: A Randomized Controlled Trial
, , , , , , , , , , , , and
JAMA. ;287():1541-1547.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Levosimendan in Cardiac Surgery: A Unique Drug for the Treatment of Perioperative Left Ventricular Dysfunction or Just Another Inodilator Searching for a Clinical Application?
Pagel
Anesth. Analg. 2007;104:759-761.
FULL TEXT  

ATP flux through creatine kinase in the normal, stressed, and failing human heart
Weiss et al.
Proc. Natl. Acad. Sci. USA 2005;102:808-813.
ABSTRACT | FULL TEXT  

Epidemiology and Pharmacotherapy of Acute Heart Failure
Vroom
SEMIN CARDIOTHORAC VASC ANESTH 2003;7:3-12.
 

OPTIME in CHF trial: rethinking the use of inotropes in the management of worsening chronic heart failure resulting in hospitalization
Gheorghiade et al.
Eur J Heart Fail 2003;5:9-12.
FULL TEXT  

A Look at Two Treatments for Acute CHF
Journal Watch Cardiology 2002;2002:4-4.
FULL TEXT